We administered a SIRT2 inhibitor to APP/PS1 mice, a model for AD, and found beneficial effects in the CNS: improved memory and learning, decreased amyloid pathology, and reduced neuroinflammation. The gene discussed is SIRT2; the disease is Alzheimer disease.